Skip to Main Content

Paper Details

Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.
Neurology
11
2022
Author NameAffiliation
Katharina M BuslUniversity of Florida
Judy IllesUniversity of British Columbia
Matthew P KirschenChildren's Hospital of Pennsylvania
  • 1 - 3

Datasets

Release 1.2